{
  "run_id": "RUN_20260204_132700_1fed028ce5fb",
  "timestamp": "2026-02-04T16:34:00.164911",
  "document": "08_bmj.m1070.full.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/PAPERS/08_bmj.m1070.full.pdf",
  "pipeline_version": "0.8",
  "total_recommendation_sets": 1,
  "total_recommendations": 3,
  "recommendation_sets": [
    {
      "guideline_name": "ANCA associated vasculitis - Clinical Practice Guideline 2020",
      "guideline_year": 2020,
      "organization": "BMJ",
      "target_condition": "ANCA associated vasculitis",
      "target_population": null,
      "recommendations": [
        {
          "recommendation_id": "rec_08_bmj.m1070.full_1",
          "recommendation_type": "treatment",
          "population": "people with chronic systemic symptoms",
          "condition": "suspected AAV",
          "severity": "any",
          "action": "Consider ANCA associated vasculitis in people with evidence of renal, pulmonary, ear, nose, and throat, ophthalmic, or peripheral nerve disease",
          "action_description": null,
          "preferred": "not specified",
          "alternatives": [],
          "dosing": [],
          "taper_target": "not specified",
          "duration": "not specified",
          "stop_window": null,
          "evidence_level": "expert_opinion",
          "strength": "strong",
          "references": [],
          "source": "08_bmj.m1070.full",
          "source_text": "Consider ANCA associated vasculitis (AAV) in people with chronic systemic symptoms and evidence of renal, pulmonary, ear, nose, and throat, ophthalmic, or peripheral nerve disease",
          "page_num": null
        },
        {
          "recommendation_id": "rec_08_bmj.m1070.full_2",
          "recommendation_type": "treatment",
          "population": "people presenting with persistent systemic symptoms",
          "condition": "suspected AAV",
          "severity": "any",
          "action": "Perform urinalysis in people presenting with persistent systemic symptoms and in those with specific features of vasculitis",
          "action_description": null,
          "preferred": "urinalysis",
          "alternatives": [],
          "dosing": [],
          "taper_target": "not specified",
          "duration": "not specified",
          "stop_window": null,
          "evidence_level": "expert_opinion",
          "strength": "strong",
          "references": [],
          "source": "08_bmj.m1070.full",
          "source_text": "Perform urinalysis in people presenting with persistent systemic symptoms and in those with specific features of vasculitis (scleritis, chronic dyspnoea, cough, haemoptysis, foot drop) because these individuals have a high probability of multi-system disease",
          "page_num": null
        },
        {
          "recommendation_id": "rec_08_bmj.m1070.full_3",
          "recommendation_type": "treatment",
          "population": "patients with haemoptysis plus other features of AAV",
          "condition": "suspected pulmonary haemorrhage",
          "severity": "urgent",
          "action": "warrant same day hospital assessment to evaluate for pulmonary haemorrhage",
          "action_description": null,
          "preferred": "same day hospital assessment",
          "alternatives": [],
          "dosing": [],
          "taper_target": "not specified",
          "duration": "not specified",
          "stop_window": null,
          "evidence_level": "expert_opinion",
          "strength": "strong",
          "references": [],
          "source": "08_bmj.m1070.full",
          "source_text": "Patients with haemoptysis plus other features of AAV warrant same day hospital assessment to evaluate for pulmonary haemorrhage",
          "page_num": null
        }
      ],
      "source_document": "08_bmj.m1070.full",
      "extraction_confidence": 0.85
    }
  ]
}